The NPS landscape is changing rapidly, requiring laboratories to constantly remain abreast of new and emerging drugs locally, nationally, and internationally. To meet individualized needs, laboratories amend existing methods or develop new ones for detection and confirmation of NPS. This can be challenging for scientists as information about NPS detections can be regionalized and/or out-of-date, making it difficult to determine which drugs should be prioritized at a given time. CFSRE’s NPS Discovery and the SOFT NPS Committee have established the below recommendations for NPS scope based on information from extensive collaborations, partnerships, and initiatives which yield national and international perspectives. Suggested cut-off concentrations or reporting limits (in ng/mL) are listed for each NPS. These values are categorized (i.e., <1, 1-10, and >10 ng/mL) and determined based on currently available quantitative data and/or comparison to structurally similar NPS within the given sub-class. (Publisher abstract provided.)
Downloads
Similar Publications
- Nanopore Sequencing: An Enrichment-free Alternative to Mitochondrial DNA Sequencing
- Accurate and rapid electrochemical detection of fentanyl in hydrophobic ionic liquid at subzero temperatures
- “They had to change the model to fit the victim, versus the victim having to fit the model”: Innovative solutions in community response to commercial sexual exploitation